BioCentury | Mar 9, 2019
Regulation

Sharpless has the edge on FDA job

...researcher. As founder of cancer company G1 Therapeutics Inc. in 2008, and lab services company HealthSpan...
...senior communications adviser. Companies and Institutions Mentioned G1 Therapeutics Inc. (NASDAQ:GTHX), Research Triangle Park, N.C. HealthSpan Diagnostics LLC...
...Bethesda, Md. University of North Carolina at Chapel Hill, Chapel Hill, N.C. Steve Usdin, Washington Editor G1 Therapeutics HealthSpan Diagnostics LLC National...
BioCentury | Jan 4, 2019
Tools & Techniques

Making AD mice as diverse as patients

...a hypothesis it is actively investigating. It’s also using the mice to test lifespan- and healthspan-extending...
BioCentury | Jan 19, 2018
Financial News

Y Combinator launches YC Bio to fund age-related start-ups

...the YC Bio incubator on Jan. 12 to fund early stage, preclinical biotechs focused on healthspan...
BioCentury | Jan 12, 2018
Financial News

Y Combinator launches YC Bio to fund age-related start-ups

...Y Combinator launched the YC Bio incubator to fund early stage, preclinical biotechs focused on healthspan...
BioCentury | Jan 4, 2018
Strategy

Seeking precision at NCI

...industry experience, having founded cancer company G1 Therapeutics Inc. in 2008, and lab services company HealthSpan...
...area as well. Companies and Institutions Mentioned G1 Therapeutics Inc. (NASDAQ:GTHX), Research Triangle Park, N.C. HealthSpan...
BioCentury | Sep 1, 2017
Financial News

Longevity closes second fund at $22M

...to 10 companies, with investments focused on companies with "the potential to impact the human healthspan."...
BioCentury | Aug 23, 2017
Financial News

Longevity closes second fund at $22M

...to 10 companies, with investments focused on companies with "the potential to impact the human healthspan."...
BioCentury | Nov 12, 2001
Company News

Disease Sciences, HealthSpan Sciences Inc. deal

...DISE acquired a majority interest in HealthSpan, which develops small molecules for cancer, cardiovascular disease, macular...
...cancer, cardiovascular disease, macular degeneration and infectious diseases. Disease Sciences Inc. (DISE), Boca Raton, Fla. HealthSpan...
Items per page:
1 - 8 of 8
BioCentury | Mar 9, 2019
Regulation

Sharpless has the edge on FDA job

...researcher. As founder of cancer company G1 Therapeutics Inc. in 2008, and lab services company HealthSpan...
...senior communications adviser. Companies and Institutions Mentioned G1 Therapeutics Inc. (NASDAQ:GTHX), Research Triangle Park, N.C. HealthSpan Diagnostics LLC...
...Bethesda, Md. University of North Carolina at Chapel Hill, Chapel Hill, N.C. Steve Usdin, Washington Editor G1 Therapeutics HealthSpan Diagnostics LLC National...
BioCentury | Jan 4, 2019
Tools & Techniques

Making AD mice as diverse as patients

...a hypothesis it is actively investigating. It’s also using the mice to test lifespan- and healthspan-extending...
BioCentury | Jan 19, 2018
Financial News

Y Combinator launches YC Bio to fund age-related start-ups

...the YC Bio incubator on Jan. 12 to fund early stage, preclinical biotechs focused on healthspan...
BioCentury | Jan 12, 2018
Financial News

Y Combinator launches YC Bio to fund age-related start-ups

...Y Combinator launched the YC Bio incubator to fund early stage, preclinical biotechs focused on healthspan...
BioCentury | Jan 4, 2018
Strategy

Seeking precision at NCI

...industry experience, having founded cancer company G1 Therapeutics Inc. in 2008, and lab services company HealthSpan...
...area as well. Companies and Institutions Mentioned G1 Therapeutics Inc. (NASDAQ:GTHX), Research Triangle Park, N.C. HealthSpan...
BioCentury | Sep 1, 2017
Financial News

Longevity closes second fund at $22M

...to 10 companies, with investments focused on companies with "the potential to impact the human healthspan."...
BioCentury | Aug 23, 2017
Financial News

Longevity closes second fund at $22M

...to 10 companies, with investments focused on companies with "the potential to impact the human healthspan."...
BioCentury | Nov 12, 2001
Company News

Disease Sciences, HealthSpan Sciences Inc. deal

...DISE acquired a majority interest in HealthSpan, which develops small molecules for cancer, cardiovascular disease, macular...
...cancer, cardiovascular disease, macular degeneration and infectious diseases. Disease Sciences Inc. (DISE), Boca Raton, Fla. HealthSpan...
Items per page:
1 - 8 of 8